PF-Atlas › Clinical Trials › NCT00005110
A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis
Salmeterol · Not specified
Registry ID
NCT00005110
Phase
Not specified
Status
Suspended
Drug / intervention
Salmeterol
Sponsor
National Center for Research Resources (NCRR)
Locations
1
About this trial
Long term use of bronchodilators in CF is beneficial to the improvement of pulmonary function and symptoms. This study is investigating the long-term benefit of administration of the drug Salmeterol, a bronchodilator. Salmeterol will be compared to albuterol or placebo. The medication will be inhaled twice a day for 6 months.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00005110 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.